Viewing Study NCT01450605


Ignite Creation Date: 2025-12-25 @ 3:11 AM
Ignite Modification Date: 2026-01-07 @ 9:33 PM
Study NCT ID: NCT01450605
Status: COMPLETED
Last Update Posted: 2016-04-21
First Post: 2011-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Korean Post-marketing Surveillance for Reyataz®
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module